StemCell Institute Inc. (7096.T)
JPY 1275.0
(0.63%)
JPY 1275.0
(0.63%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.48 Billion JPY | 18.64% |
| 2022 | 2.09 Billion JPY | 17.36% |
| 2021 | 1.78 Billion JPY | 26.42% |
| 2020 | 1.4 Billion JPY | -15.9% |
| 2019 | 1.67 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 678 Million JPY | 13.7% |
| 2023 Q2 | 636.45 Million JPY | 10.28% |
| 2023 Q4 | 596.28 Million JPY | -11.18% |
| 2023 Q3 | 671.34 Million JPY | 5.48% |
| 2023 FY | 2.48 Billion JPY | 18.64% |
| 2023 Q1 | 577.1 Million JPY | 12.7% |
| 2022 Q3 | 542.78 Million JPY | -0.14% |
| 2022 FY | 2.09 Billion JPY | 17.36% |
| 2022 Q4 | 512.09 Million JPY | -5.65% |
| 2022 Q2 | 543.57 Million JPY | 0.0% |
| 2021 FY | 1.78 Billion JPY | 26.42% |
| 2020 FY | 1.4 Billion JPY | -15.9% |
| 2019 FY | 1.67 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 47.984% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -2097.185% |
| GNI Group Ltd. | 26.01 Billion JPY | 90.461% |
| Linical Co., Ltd. | 12.3 Billion JPY | 79.841% |
| Trans Genic Inc. | 13.08 Billion JPY | 81.036% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -275.061% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 51.9% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | -59.011% |
| AnGes, Inc. | 152.98 Million JPY | -1521.854% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -306.674% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 80.564% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -203.807% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -1731.031% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | -52.605% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -479.225% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | -30.507% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -263.564% |
| Kidswell Bio Corporation | 2.43 Billion JPY | -2.055% |
| PeptiDream Inc. | 28.71 Billion JPY | 91.358% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -3836.027% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -1950.573% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -3446001.389% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -6120.556% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 44.991% |
| FunPep Company Limited | 530 Thousand JPY | -468049.623% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -3482.95% |
| Stella Pharma Corporation | 269.49 Million JPY | -820.696% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -683.16% |
| Cuorips Inc. | 23.1 Million JPY | -10640.165% |
| K Pharma,Inc. | 1 Billion JPY | -148.119% |
| Takara Bio Inc. | 43.5 Billion JPY | 94.297% |
| ReproCELL Incorporated | 2.42 Billion JPY | -2.241% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | -44.649% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 1.312% |
| CellSeed Inc. | 190.13 Million JPY | -1204.971% |